MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

NuVasive Company Profile (NASDAQ:NUVA)

Consensus Ratings for NuVasive (NASDAQ:NUVA) (?)
Ratings Breakdown: 3 Hold Rating(s), 9 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $61.00 (5.30% upside)

Analysts' Ratings History for NuVasive (NASDAQ:NUVA)
Show:
DateFirmActionRatingPrice TargetActions
6/6/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/7/2016Morgan StanleyReiterated RatingHold$57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/7/2016Brean CapitalReiterated RatingBuy$58.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2016Piper JaffrayReiterated RatingOverweight$58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2016BarclaysUpgradeEqual Weight -> Overweight$58.00 -> $63.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Leerink SwannReiterated RatingBuy$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Needham & Company LLCReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Cowen and CompanyReiterated RatingBuy$52.00 -> $63.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/11/2015Bank of AmericaUpgradeUnderperform -> Neutral$56.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2015BMO Capital MarketsUpgradeMarket Perform -> Outperform$52.00 -> $64.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/5/2015RBC CapitalReiterated RatingOutperform$58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015Northland SecuritiesUpgradeMarket Perform -> Outperform$48.00 -> $68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2015Goldman SachsDowngradeBuy -> Neutral$52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2015WallachBeth CapitalBoost Price TargetBuy$49.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2015Robert W. BairdBoost Price TargetOutperform$50.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2015Summer StreetDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2015Jefferies GroupBoost Price TargetBuy$48.00 -> $63.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2014Wells FargoUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for NuVasive (NASDAQ:NUVA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/26/2016        
4/26/2016Q116$0.27$0.31$205.54 million$215.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/11/2016Q415$0.31$0.35$215.08 million$215.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2015Q315$0.27$0.35$200.21 million$200.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2015Q215$0.25$0.31$200.71 million$202.91 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/4/2015Q115$0.21$0.30$189.30 million$192.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2015Q4$0.37$0.39$201.40 million$204.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314$0.25$0.19$179.30 million$189.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2014Q214$0.25$0.28$177.50 million$190.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2014Q114$0.23$0.29$171.30 million$177.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2014Q413$0.32$0.37$181.24 million$190.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2013Q313$0.24$0.39$158.30 million$169.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2013Q2 2013$0.23$0.20$161.67 million$165.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2013Q1 2013$0.22$0.26$157.34 million$159.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2013Q4 2012$0.21$0.34$156.35 million$165.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2012$0.21$0.23ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2012$0.23$0.27ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2012$0.18$0.20ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/22/2012$0.22$0.27ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2011$0.24$0.26ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2011$0.28$0.30ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2011$0.19$0.24ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2011$0.42$0.46ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for NuVasive (NASDAQ:NUVA)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.25$0.32$0.29
Q2 20166$0.33$0.39$0.37
Q3 20166$0.33$0.41$0.37
Q4 20165$0.42$0.47$0.45
Q1 20171$0.34$0.34$0.34
Q2 20171$0.47$0.47$0.47
Q3 20171$0.49$0.49$0.49
Q4 20171$0.60$0.60$0.60
(Data provided by Zacks Investment Research)
Dividend History for NuVasive (NASDAQ:NUVA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for NuVasive (NASDAQ:NUVA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/16/2016Jason HannonEVPSell14,534$57.57$836,722.38View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/6/2016Patrick MilesCOOSell10,723$54.03$579,363.69View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2015Patrick MilesCOOSell9,127$52.56$479,715.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/7/2015Quentin S BlackfordCFOSell15,000$51.10$766,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2015Patrick MilesCOOSell5,873$52.51$308,391.23View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015Patrick MilesCOOSell15,000$48.12$721,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/5/2015Matthew LinkinsiderSell1,714$50.72$86,934.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2015Quentin S BlackfordCFOSell5,000$36.30$181,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2015Patrick MilesCOOSell15,000$48.10$721,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2015Russell PowersEVPSell5,806$51.64$299,821.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2015Jason HannonEVPSell11,962$52.02$622,263.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015Patrick MilesCOOSell15,000$52.03$780,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/31/2015Patrick MilesCOOSell15,000$53.34$800,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/20/2015Jason HannonEVPSell15,000$49.60$744,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015Gregory T LucierCEOBuy4,491$49.49$222,259.59View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2015Gregory T LucierCEOBuy8,000$50.10$400,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2015Gregory T LucierCEOBuy10,000$49.10$491,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2015Gregory T LucierCEOBuy10,000$49.26$492,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Gregory T LucierCEOBuy10,000$49.71$497,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2015Gregory T LucierCEOBuy8,000$49.96$399,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2015Patrick MilesCOOSell4,194$49.47$207,477.18View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2015Jack R BlairDirectorSell3,703$50.16$185,742.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2015Gregory T LucierCEOBuy34,000$49.25$1,674,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2015Russell PowersEVPSell8,042$49.00$394,058.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2015Patrick MilesCOOSell15,000$47.52$712,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2015Russell PowersEVPSell11,881$45.21$537,140.01View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/24/2015Russell PowersEVPSell3,888$44.07$171,344.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2015Patrick MilesCOOSell7,920$45.52$360,518.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2015Alexis V LukianovCEOSell5,313$44.82$238,128.66View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2015Matthew LinkInsiderSell7,500$44.46$333,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Jason HannonEVPSell5,085$45.06$229,130.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2015Alexis V LukianovCEOSell5,454$46.10$251,429.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2015Matthew LinkInsiderSell4,078$45.77$186,650.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Patrick MilesCOOSell15,000$45.53$682,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/28/2015Keith ValentineCOOSell6,970$46.96$327,311.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2015Alexis V LukianovCEOSell7,452$49.69$370,289.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Jason HannonEVPSell12,117$46.82$567,317.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Patrick MilesInsiderSell15,000$46.61$699,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/30/2014Jason HannonEVPSell15,000$47.63$714,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/29/2014Jason HannonEVPSell3,146$47.57$149,655.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/24/2014Patrick MilesInsiderSell15,000$47.52$712,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/19/2014Keith ValentineCOOSell5,893$47.78$281,567.54View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Keith ValentineCOOSell2,500$43.66$109,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2014Keith ValentineCOOSell5,582$43.32$241,812.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2014Quentin S BlackfordCFOSell7,698$43.41$334,170.18View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2014Alexis V LukianovCEOSell25,000$41.40$1,035,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Keith ValentineCOOSell2,500$40.61$101,525.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/2/2014Keith ValentineCOOSell2,500$35.00$87,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Keith ValentineCOOSell2,500$35.14$87,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014Keith ValentineCOOSell2,500$37.11$92,775.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014Michael LambertCFOSell4,010$37.11$148,811.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2014Jason HannonEVPSell5,000$39.00$195,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/10/2014Russell PowersEVPSell3,200$33.43$106,976.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Keith ValentineCOOSell2,500$35.65$89,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Michael LambertCFOSell23,225$35.48$824,023.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2014Keith ValentineCOOSell5,000$35.00$175,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2014Russell PowersEVPSell9,526$35.00$333,410.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2014Robert HuntDirectorSell20,000$34.25$685,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2014Michael LambertCFOSell13,096$33.07$433,084.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2014Keith ValentineCOOSell2,500$38.41$96,025.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2014Peter FarrellDirectorSell48,000$36.88$1,770,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/21/2014Jason HannonEVPSell10,095$36.60$369,477.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2014Keith ValentineCOOSell20,000$37.96$759,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2014Alexis LukianovCEOSell34,217$34.29$1,173,300.93View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2014Craig HunsakerSVPSell4,980$35.00$174,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/30/2013Craig HunsakerSVPSell4,275$32.10$137,227.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/23/2013Michael LambertCFOSell17,091$32.49$555,286.59View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2013Alexis LukianovCEOSell5,000$31.45$157,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2013Jason HannonEVPSell2,334$28.90$67,452.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2013Patrick MilesInsiderSell21,223$31.10$660,035.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2013Patrick MilesInsiderSell7,331$25.72$188,553.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/21/2013Russell PowersVPSell12,500$25.39$317,375.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/11/2013Jason HannonEVPSell1,000$26.00$26,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/7/2013Jason HannonEVPSell8,705$23.99$208,832.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/7/2013Michael LambertCFOSell15,442$24.04$371,225.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/6/2013Richard Treharne IIIDirectorBuy2,000$23.26$46,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/12/2013Craig E HunsakerSVPSell2,000$27.00$54,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/8/2013Alexis V LukianovCEOSell5,000$25.74$128,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2013Keith ValentineCOOSell1,698$25.00$42,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Alexis V LukianovCEOSell7,500$22.71$170,325.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2013Peter Michael LeddyDirectorBuy2,400$22.24$53,376.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2013Alexis V LukianovCEOSell12,500$22.11$276,375.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for NuVasive (NASDAQ:NUVA)
DateHeadline
06/24/16 08:09 AMWhat Investors are Making of These Healthcare Stocks? - Antares Pharma, Globus Medical, NuVasive, and Insulet
06/21/16 05:07 PMInteresting NUVA Put And Call Options For August 19th
06/21/16 05:07 PMA Look At Fed. Circ. Induced Infringement Ruling In NuVasive
06/20/16 05:23 PMNuVasive, Inc. Upside Stock Momentum at Extreme Strength - CML News
06/20/16 07:10 AMThis Weeks Broker Views For NuVasive, Inc. (NASDAQ:NUVA) - Fiscal Standard
06/17/16 08:20 AMObjectively Unreasonable Claim Construction does not Avoid Induced Infringement
06/14/16 12:13 PMExclusive: NuVasive CEO Talks M&A, Brazil, And The Company's Biggest Weakness - The Benzinga news desk recently had the opportunity to speak with Greg Lucier, CEO of NuVasive, Inc. (NASDAQ: NUVA). Below is a partial transcript of the call. BZ: Want to start off with the Biotronic acquisition, an Ann Arbor company. You mentioned the service footprint in your PR. I wanted to find out what attracted you in terms of the geographic coverage. Why did this specific market appeal to Nuvasive? Greg: We at NuVasive already had a service business, but did this neural monitoring of spine surgeries and our business was positioned geographically in a way that the acquisition of Biotronic would complement. So where Biotronic was located was where we were not. So this acquisition allowed us to expand our footprint demonstrably in more geographies and therefore cover more surgeries than we had in the past. BZ: You mentioned the deal would be accretive. I don't know if you had spoken to your CFO or any of the other management team yet. Is there any idea, maybe single, double digits in terms of what this might be accretive to going forward? Greg: What we said in the press release was it was supportive of our guidance in terms of revenue growth percentage, our expansion of operating margin, and also supporting the return on invested capital goals we've laid out in the past, but in terms of specific numbers, we're going to wait until the deal closes and then give that updated guidance at our second quarter earnings call. BZ: I watched your interview with Kramer last week and they mentioned Brazil so I know that you guys acquired your Brazilian distributor. Was there any concern with any of the macro environment and turmoil that might be going on down there or do you really think maybe you're getting in at a good time and got a good deal because of maybe some of ...Full story available on Benzinga.com
06/11/16 08:22 AMNuVasive Inc. (NUVA) Hits New 52-week High During June 09 Session - Equities.com
06/10/16 05:48 PMWill NuVasive, Inc. (NASDAQ:NUVA) Surprise This Quarter? - Investor Newswire
06/10/16 08:25 AMWhy NuVasive (NUVA) Could Beat Earnings Estimates Again -
06/09/16 05:54 PMNuVasive, Inc. (NASDAQ:NUVA) Fundamental Star Rating Report - CML News
06/09/16 08:28 AMNuVasive Inc. (NUVA) Hits New 52-week High During June 07 Session - Equities.com
06/08/16 05:55 PMSummary of Price Movements: NuVasive, Inc. (NASDAQ:NUVA) , Stryker Corporation (NYSE:SYK) - Street Updates
06/08/16 05:55 PMAnalyst Opinions on: NuVasive, Inc. (NASDAQ:NUVA), Windstream Holdings, Inc. (NASDAQ:WIN) - Beacon Chronicle
06/08/16 08:33 AMAnalysts Offer Insights on Healthcare Companies: NuVasive Inc (NASDAQ: NUVA), Alexion (NASDAQ: ALXN) and ... - Analyst Ratings
06/08/16 08:33 AMNuVasive Inc. (NUVA) Hits New 52-week High During June 06 Session - Equities.com
06/08/16 08:33 AMNuVasive Inc (NUVA) Raising PT on Accretive Acquisition - Brean Capital - StreetInsider.com
06/07/16 05:47 PMMedical device company acquires Biotronic for $98M
06/07/16 05:47 PMNuVasive enters agreement to acquire Biotronic NeuroNetwork
06/07/16 05:47 PMNuVasive Inc (NUVA) Raising PT on Accretive Acquisition - Brean Capital
06/07/16 05:47 PMNuVasive picks up neuro monitoring provider Biotronic NeuroNetwork for $98m
06/07/16 07:17 AMNuVasive to Strengthen Spine Service Line with Biotronic Buy -
06/06/16 04:15 PMBRIEF-NuVasive to acquire Biotronic NeuroNetwork - * Board of directors of both companies have unanimously approved transaction
06/06/16 03:18 PMNuVasive to Acquire Biotronic NeuroNetwork - [at noodls] - SAN DIEGO, CA -- (Marketwired) -- 06/06/16 -- Enhances NuVasive's Spine Service Line Partnership Offerings Doubles Size of NuVasive's Service Platform with Complementary Geographic Footprint Expanded Platform ...
06/06/16 03:12 PMNUVASIVE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and E -
06/04/16 08:26 AMFed Circ. Backs NuVasive Surgical Patent Win Post-Commil
06/04/16 08:26 AMAppeals court again upholds NuVasive in patent win over Medtronic
06/03/16 10:02 AMNuVasive, Inc. :NUVA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 3, 2016 -
06/03/16 09:55 AMMoving Average Crossover Alert: NuVasive (NUVA) -
06/03/16 05:00 AMJim Cramer's Top Takeaways: Ross Stores, TJX, Tesla, NXP Semiconductor, NuVasive -
05/31/16 08:04 AMNuVasive Inc.: NuVasive to Participate in Investor Events in June 2016 - SAN DIEGO, CA -- (Marketwired) -- 05/31/16 -- NuVasive, Inc.(NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will ...
05/31/16 06:12 AMNuVasive to Participate in Investor Events in June 2016 - [at noodls] - SAN DIEGO, CA -- (Marketwired) -- 05/31/16 -- NuVasive, Inc.(NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, ...
05/31/16 06:01 AMNuVasive Poised on Solid International Sales, Scope in Spine -
05/30/16 09:02 PMNuVasive, Inc. (NUVA) To Report June 2016 Results - NuVasive, Inc. (NUVA) added 3.08% to reach at the floor price of $54.96 as the company is set to share its next quarterly earnings on July 26, 2016. NUVA stock trades between $53.25 and $55.21 before the earnings release. Let’s take a closer look at the ...
05/28/16 12:33 PMGhost Tree Capital LLC Decreased Stake in Nuvasive INC (NASDAQ:NUVA) by $7.68 Million as Shares Declined - CCH Daily News - Risers & FallersGhost Tree Capital LLC Decreased Stake in Nuvasive INC (NASDAQ:NUVA) by $7.68 Million as Shares DeclinedCCH Daily NewsKen Greenberg decreased its stake in Nuvasive Inc (NASDAQ:NUVA) by 69.57% based on its latest 2016Q1 regulatory filing with the SEC. Ghost Tree Capital Llc sold 160,000 shares as the company's stock declined 6.89% while stock markets rallied.NuVasive, Inc. (NUVA) Upgraded to "Overweight" by BarclaysThe Cerbat GemUpgrades And Downgrades For NuVasive, Inc. (NASDAQ:NUVA)Risers & FallersIs it Time to Cash in Profits on NuVasive, Inc. (NASDAQ:NUVA)Franklin IndependentSonoran Weekly Review -Market Digestall 7 news articles »
05/27/16 01:17 PMPalo Alto Draws Downgrades; Splunk Targets Hiked; NuVasive A Buy -
05/27/16 11:43 AMNuVasive upgraded by Barclays -
05/27/16 08:43 AMNuVasive (NUVA) Stock Upgraded at Barclays -
05/26/16 12:37 PMBroker Roundup For NuVasive, Inc. (NASDAQ:NUVA) - Share Trading News - Broker Roundup For NuVasive, Inc. (NASDAQ:NUVA)Share Trading News04/27/2016 – NuVasive, Inc. had its “overweight” rating reiterated by analysts at Piper Jaffray. They now have a USD 58 price target on the stock. 01/06/2016 – NuVasive, Inc. had its “outperform” rating reiterated by analysts at Leerink Swann. They now ...and more »
05/26/16 12:37 PMNuVasive, Inc. (NASDAQ:NUVA): Reviewing Share Performance - Wall Street Hints and News - NuVasive, Inc. (NASDAQ:NUVA): Reviewing Share PerformanceWall Street Hints and NewsNuVasive, Inc. (NASDAQ:NUVA) shares have traded -1.26% in the latest trading session. During the session, the stock moved to a high of $53.95 and dipped to a low of $53.06. Shares have been recently noted at +2.13% away from the 50 day moving ...and more »
05/21/16 01:58 PMCamber Capital Management LLC Increased Nuvasive INC (NASDAQ:NUVA) by $19.20 Million as Shares Declined - CCH Daily News - Camber Capital Management LLC Increased Nuvasive INC (NASDAQ:NUVA) by $19.20 Million as Shares DeclinedCCH Daily NewsStephen Dubois increased its stake in Nuvasive Inc. (NASDAQ:NUVA) by 36.36% based on its latest 2016Q1 regulatory filing with the SEC. Camber Capital Management Llc bought 400,000 shares as the company's stock declined 6.89% while stock markets ...
05/20/16 04:08 PMNUVASIVE INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/19/16 02:00 PMNuVasive, Inc. (NASDAQ:NUVA) Quarterly EPS Projection At $0.38 - Investor Newswire - NuVasive, Inc. (NASDAQ:NUVA) Quarterly EPS Projection At $0.38Investor NewswireA week earlier, the EPS projection was $0.38 while 30-days ago it was $0.38. This target was set at $0.38 60 days ago and it was $0.38 90 days earlier. From a week ago, the change in estimates is 0%. EPS was revised 0 times up and 0 down in last one ...
05/19/16 02:00 PMNuVasive, Inc. (NASDAQ:NUVA): Update on Stock Performance - Wall Street Hints and News - NuVasive, Inc. (NASDAQ:NUVA): Update on Stock PerformanceWall Street Hints and NewsDuring the latest trading session, NuVasive, Inc. (NASDAQ:NUVA) shares traded -0.86%. In the trading session, the stock reached a high of $53.71 and dropped to a low of $52.73. Company shares have been recently seen +8.33% off of the 200 day moving ...and more »
05/19/16 02:00 PMEarnings View for NuVasive, Inc. (NASDAQ:NUVA) - Wall Street Hints and News - Earnings View for NuVasive, Inc. (NASDAQ:NUVA)Wall Street Hints and NewsCovering equity analysts are projecting NuVasive, Inc. (NASDAQ:NUVA) to report quarterly earnings per share of $0.36 on a consensus basis. This number uses data provided by analysts polled by Zacks Research. The estimate may vary from other data ...and more »
05/19/16 02:00 PMTraders Targeted Movers: Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) , NuVasive, Inc. (NASDAQ:NUVA) - Street Updates - Traders Targeted Movers: Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) , NuVasive, Inc. (NASDAQ:NUVA)Street UpdatesOn 5/18/2016, shares of Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) rose +5.37% in trading session and finally closed at $25.91. The company most recent volume stood at 763.11 thousand shares as compared to its average volume of 1.11 million shares.and more »
05/13/16 08:46 AMNuVasive, Inc. (NASDAQ:NUVA) One-Year Mean Price Target At $59 - RealistInvestor.com - NuVasive, Inc. (NASDAQ:NUVA) One-Year Mean Price Target At $59RealistInvestor.comSell-side analysts are confident on the future outlook of NuVasive, Inc. (NASDAQ:NUVA) stock. As of 2016-05-11, the stock has an ABR of 1.53 rating, where number 5 denotes a Strong Sell and 1 Strong Buy. The ABR is reached on the basis of estimates of ...and more »
05/13/16 06:08 AMNuVasive to Feature Game-Changing, Integrated Spine Solutions at SpineWeek 2016 - [at noodls] - SAN DIEGO, CA -- (Marketwired) -- 05/13/16 -- NuVasive, Inc.(NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, ...
05/12/16 09:02 AMPerformance Recap and Target Perspective on NuVasive, Inc. (NASDAQ:NUVA) - B.O.D.Y Confidential - Performance Recap and Target Perspective on NuVasive, Inc. (NASDAQ:NUVA)B.O.D.Y ConfidentialIn the latest trading session, shares of NuVasive, Inc. (NASDAQ:NUVA) moved -0.73%. In order to gain some further insight on stock performance, we can take a look at the stock price relative to some moving averages. After a recent check, company shares ...and more »
05/12/16 09:02 AMNuVasive, Inc. (NASDAQ:NUVA): Quarterly EPS Estimate Of $0.38 - Investor Newswire - NuVasive, Inc. (NASDAQ:NUVA): Quarterly EPS Estimate Of $0.38Investor NewswireThe EPS projection 7-days ago was $0.38 while 30-days earlier it was $0.38. The EPS projection stood at $0.38 60 days earlier and at $0.38 90 days ago. From a week earlier, the percentage change in estimates is 0%. EPS was revised 0 times up and 0 ...and more »
About NuVasive

NuVasive logoNuvasive, Inc. is a medical device company in the spine market. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine. The Company offers two product lines: spine surgery products and biologics. The Company's spine surgery products line offerings include thoracolumbar product offerings, cervical product offerings, Intra-Operative Monitoring (IOM) services and disposables, which are used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The Company's biologics product line offerings includes allograft (donated human tissue), FormaGraft (a collagen synthetic product), Osteocel Plus and Osteocel Pro (each an allograft cellular matrix containing viable mesenchymal stem cells (MSCs)), and AttraX (a synthetic bone graft material), all of which are used to aid the spinal fusion or bone healing process.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: NUVA
  • CUSIP: 67070410
Key Metrics:
  • Previous Close: $57.93
  • 50 Day Moving Average: $55.58
  • 200 Day Moving Average: $49.82
  • P/E Ratio: 117.51
  • P/E Growth: 2.67
  • Market Cap: $2.89B
  • Current Quarter EPS Consensus Estimate: $1.51 EPS
Additional Links:
NuVasive (NASDAQ:NUVA) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha